Sino Biopharmaceutic (SBMFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 06-2021 | 03-2021 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Other Operating Activity | 425,140 | 361,777 | 0 | 0 | 219,488 |
| Operating Cash Flow | $425,140 | $361,777 | $N/A | $N/A | $219,488 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,827 | N/A | N/A | N/A | N/A |
| PPE Investments | -56,275 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 194,677 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -416,425 | -628,269 | 0 | 0 | -216,389 |
| Investing Cash Flow | $-281,851 | $-628,269 | $N/A | $N/A | $-216,389 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 926,981 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -49,930 | N/A | N/A | N/A | N/A |
| Dividend Paid | -122,802 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,320,385 | -117,986 | 0 | 0 | 721,082 |
| Financing Cash Flow | $-566,136 | $-117,986 | $N/A | $N/A | $721,082 |
| Exchange Rate Effect | 3,627 | -17,622 | N/A | N/A | -13,687 |
| Beginning Cash Position | 1,036,454 | 1,645,688 | N/A | N/A | 1,500,064 |
| End Cash Position | 617,234 | 1,243,588 | N/A | N/A | 2,210,558 |
| Net Cash Flow | $-419,220 | $-402,100 | $N/A | $N/A | $710,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 425,140 | 361,777 | N/A | N/A | 219,488 |
| Capital Expenditure | -56,275 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 368,864 | 361,777 | 0 | 0 | 219,488 |